Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression

BACKGROUND: Noninvasively differentiating therapy-induced pseudoprogression from recurrent disease in patients with glioblastoma is prospectively difficult due to the current lack of a biologically specific imaging metric. Ferumoxytol iron oxide nanoparticle MRI contrast characterizes innate immunit...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Barajas, Ramon F, Hamilton, Bronwyn E, Schwartz, Daniel, McConnell, Heather L, Pettersson, David R, Horvath, Andrea, Szidonya, Laszlo, Varallyay, Csanad G, Firkins, Jenny, Jaboin, Jerry J, Kubicky, Charlotte D, Raslan, Ahmed M, Dogan, Aclan, Cetas, Justin S, Ciporen, Jeremy, Han, Seunggu J, Ambady, Prakash, Muldoon, Leslie L, Woltjer, Randy, Rooney, William D, Neuwelt, Edward A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Neuroimaging
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6422439/
https://ncbi.nlm.nih.gov/pubmed/30277536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy160
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia